US EditionPublished • loading... • Updated
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of “Hold” from Analysts
Summary by tickerreport.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bio-Rad Laboratories, Inc. (NYSE:BIO) Receives Consensus Rating of “Hold” from Analysts
Bio-Rad Laboratories, Inc. (NYSE:BIO – Get Free Report) has received a consensus rating of “Hold” from the six analysts that are currently covering the company, Marketbeat reports. One analyst has rated the stock with a sell rating, two have issued a hold rating and three have issued a buy rating on the company. The average […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
